首页> 外文期刊>Journal of Medical Virology >Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile
【24h】

Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile

机译:智利HBsAg阴性的HIV患者中,抗HBc的存在与HBV感染的高发生率和隐匿性HBV感染的低阈值有关

获取原文
获取原文并翻译 | 示例
           

摘要

HBV-HIV coinfection is prevalent. Frequently, anti-HBc is the only serological marker of HBV, which can be indicative of HBV resolved infection, when found together with anti-HBs reactivity; or present as isolated anti-HBc, related to HBV occult infection with presence of detectable DNA HBV, more prevalent in HIV-positive individuals. Regional data about this condition are scarce. Anti-HBc rapid test has been used as screening, but its performance has not been described in HIV-positive patients. The aim of this study was determine prevalence of anti-HBc in HIV-positive patients, serological pattern of HBV resolved infection and isolated anti-HBc, evaluating presence of HBV occult infection. Assess anti-HBc rapid test compared to ECLIA. Methods included measurement of anti-HBc and anti-HBs in HIV-positive patients with negative HBsAg. Serum HBV DNA quantification and HBV booster vaccination to isolated anti-HBc individuals. Detection of anti-HBc by rapid test and ECLIA. In 192 patients, prevalence of anti-HBc was 42.7% (82/192); associated to male gender, drug use, men-sex-men, positive-VDRL, and longer time HIV diagnosis. 34.4% (66/192) had presence of anti-HBs, mean titers of 637ui/ml. Isolated anti-HBc in 8.3% (16/192), associated to detectable HIV viral load and no-use of HAART; in them, HBV DNA was undetectable, and 60% responded to HBV vaccination booster. Anti-HBc rapid test showed low sensibility (32.9%) compared to ECLIA. These results show that prevalence of anti-HBc in HIV-positive individuals is high, in most cases accompanied with anti-HBs as HBV resolved infection. Low prevalence of isolated anti-HBc, with undetectable HBV DNA, and most had anamnestic response to HBV vaccination; suggest low possibility of occult HBV infection. Anti-HBc rapid test cannot be recommended as screening method for anti-HBc. J. Med. Virol. 88:639-646, 2016. (c) 2015 Wiley Periodicals, Inc.
机译:HBV-HIV合并感染很普遍。通常,抗HBc是唯一的HBV血清学标志物,当与抗HBs反应性一起发现时,可以指示HBV解决的感染。或以孤立的抗HBc形式存在,与HBV隐性感染有关,并存在可检测到的DNA HBV,在HIV阳性个体中更为普遍。关于这种情况的区域数据很少。抗HBc快速测试已用作筛查,但尚未在HIV阳性患者中描述其性能。这项研究的目的是确定在HIV阳性患者中抗HBc的患病率,HBV解析感染和分离的抗HBc的血清学模式,评估HBV隐性感染的存在。与ECLIA相比,评估抗HBc快速测试。方法包括测量HBsAg阴性的HIV阳性患者的抗HBc和抗HBs。对分离的抗HBc个体进行血清HBV DNA定量和HBV加强免疫接种。通过快速检测和ECLIA检测抗HBc。在192例患者中,抗HBc的患病率为42.7%(82/192);与男性性别,吸毒,男性-性行为,VDRL阳性和HIV诊断时间长有关。 34.4%(66/192)存在抗HBs,平均滴度为637ui / ml。分离的抗-HBc占8.3%(16/192),与可检测的HIV病毒载量和不使用HAART有关;在它们中,无法检测到HBV DNA,并且60%的人对HBV疫苗接种增强剂有反应。与ECLIA相比,抗HBc快速测试显示出较低的敏感性(32.9%)。这些结果表明,HIV阳性患者中抗HBc的患病率很高,在大多数情况下,伴有抗HBs作为HBV解决的感染。分离出的抗-HBc的患病率低,HBV DNA不可检测,并且大多数对HBV疫苗有记忆消除作用;提示隐匿性HBV感染的可能性低。不建议将抗HBc快速检测作为抗HBc的筛查方法。 J. Med。病毒。 88:639-646,2016.(c)2015威利期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号